Elisa Funck-Brentano

7PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 15, 2023
Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis.

Lorenz H Lehmann, Markus B Heckmann, Guillaume Bailly

|Aug 22, 2022
Reply to A. Ruggiero et al. to our article 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity'.

Rafaele Molinier, Anissa Roger, Bastien Genet

|Jun 10, 2022
Formalin-fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma.

L Gonzalez-Lara, B Bonsang, U Zimmermann

|Nov 09, 2021
Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity.

R Molinier, A Roger, B Genet

|Jul 15, 2021
Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma.

Sarah Bouchereau, Louise Chaplain, Magali Fort

|Oct 24, 2020
Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies.

E Charvet, N Kramkimel, L Chaplain

Pageof 2

Frequent Collaborators

3 joint publications

Anissa Roger

2 joint publications

C Longvert

2 joint publications

P Saiag

1 joint publications

N Kramkimel